TREACE MEDICAL CONCEPTS, INC. (TMCI)
Health Care · Orthopedic surgical devices / foot and ankle surgery devices · Nasdaq
Treace is a focused orthopedic medical device company specializing in innovative 3D bunion correction and foot surgery systems for hospitals and surgical centers.
What TREACE MEDICAL CONCEPTS, INC. does
Treace Medical Concepts designs and commercializes surgical devices for bunion correction and related foot procedures. The company's flagship product is the Lapiplasty® system, a 3D-correction surgical fixation system for bunion procedures performed in hospitals and ambulatory surgery centers. Treace also offers osteotomy and great toe fusion systems to address additional foot surgical indications.
Themes: ["bunion surgery / foot orthopedics","surgical devices","orthopedic medical devices","ambulatory surgery center adoption"]
Fundamentals
- Price$4.32 as of 2026-07-10 close
- Market cap$280M as of 2026-07-13
- 1-year return-30.4% as of 2026-07-10 close
- Net margin-29.4% as of 2026-07-13
- Gross margin+79.7% as of 2026-07-13
- ROE-69.5% as of 2026-07-13
- Debt / equity0.72 as of 2026-07-13
- Revenue growth (YoY)-1.7% as of 2026-07-13
- Revenue CAGR (3y)+14.5% SEC XBRL
- Beta1.41 as of 2026-07-13
Key risks (from latest filing)
["Significant market competition with new product introductions from competitors in both Lapidus and minimally invasive osteotomy segments","Shift in elective bunion surgery care settings from hospitals to ambulatory surgery centers, affecting market dynamics and pricing","Company is unprofitable with negative 29.44% net margin; dependent on controlling expenses and achieving profitability while managing revenue growth challenges"]
Competitors & peers
- Smith & Nephew (SNN)
- Wright Medical Group (WMGI)
- Arthrex
- Zimmer Biomet (ZBH)
Fundamentals: Finnhub, as of 2026-07-13. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.